Innospec/$IOSP
1D1W1MYTD1Y5YMAX
Capital at risk
About Innospec
Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Performance Chemicals segment that derives maximum revenue, provides technology-based solutions for its customers' processes or products in personal care, home care, agrochemical, construction, mining and other industrial markets. The Fuel Specialties segment develops, manufactures, blends, markets and supplies a range of specialty chemical products used as additives in diesel, jet, marine, fuel oil and other fuels. The Oilfield Services segment develops and markets chemical solutions for drilling, completion, production, DRA and oil and gas applications.
- Ticker
- $IOSP
- Sector
- Materials
- Primary listing
- NASDAQ
- Employees
- 2,450
- Headquarters
- Englewood, United States
- Website
- innospec.com
Innospec Metrics
BasicAdvanced
$2.3B
19.05
$4.90
0.91
$1.79
1.97%
Price and volume
Market cap
$2.3B
Beta
0.91
52-week high
$96.68
52-week low
$65.51
Average daily volume
171K
Dividend rate
$1.79
Financial strength
Current ratio
2.784
Quick ratio
1.79
Long term debt to equity
2.487
Total debt to equity
3.546
Dividend payout ratio (TTM)
36.46%
Profitability
EBITDA (TTM)
191
Gross margin (TTM)
27.46%
Net profit margin (TTM)
6.60%
Operating margin (TTM)
8.12%
Effective tax rate (TTM)
14.78%
Revenue per employee (TTM)
$750,000
Management effectiveness
Return on assets (TTM)
5.12%
Return on equity (TTM)
9.13%
Valuation
Price to earnings (TTM)
19.052
Price to revenue (TTM)
1.255
Price to book
1.71
Price to tangible book (TTM)
2.59
Price to free cash flow (TTM)
46.89
Free cash flow yield (TTM)
2.13%
Free cash flow per share (TTM)
1.991
Dividend yield (TTM)
1.92%
Forward dividend yield
1.97%
Growth
Revenue change (TTM)
2.87%
Earnings per share change (TTM)
535.50%
3-year revenue growth (CAGR)
-2.93%
10-year revenue growth (CAGR)
6.96%
3-year earnings per share growth (CAGR)
-0.93%
10-year earnings per share growth (CAGR)
0.43%
3-year dividend per share growth (CAGR)
10.13%
10-year dividend per share growth (CAGR)
10.83%
What the Analysts think about Innospec
Analyst ratings (Buy, Hold, Sell) for Innospec stock.
Analyst projections of the future price of Innospec stock.
Bulls say / Bears say
In Q4 2025, Innospec generated $61.4 million in operating cash flow and boosted net cash to $292.5 million, providing strong liquidity for growth initiatives (Reuters).
The company increased its semi-annual dividend by 10% and repurchased $10.7 million of stock in Q3 2025, underscoring management’s commitment to returning capital to shareholders (Reuters).
Management reiterated expectations for sequential operating income growth in both Performance Chemicals and Oilfield Services following Q3 2025 results, signaling confidence in its operational improvement plans (Reuters).
Innospec’s Q4 2025 revenue fell 2% to $455.6 million versus the $460.9 million consensus, indicating softer demand in its core specialty chemicals markets (Reuters).
In Q3 2025, adjusted EPS came in at $1.12, missing the $1.18 analyst estimate due to gross margin contraction across its business lines (Reuters).
Oilfield Services operating income declined in Q3 2025 on weaker Middle East activity and customer timing issues, highlighting ongoing volatility in that high-margin segment (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 29 Aug 2026.
Innospec Financial Performance
Revenues and expenses
Innospec Earnings Performance
Company profitability
Upcoming events
No upcoming events
Innospec News
AllArticlesVideos
Funds containing Innospec
AllUSDGBPEUR
Fund name | Fund size | $IOSP weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.12% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.12% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.07% |
iShares MSCI World Small Cap$WSML | $9B | 0.02% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.02% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.